• 1. Enabling shape memory and healable effects in a conjugated polymer by incorporating siloxane via dynamic imine bond?
  Yaling Zhang,Chunhui Dai,Shiwei Zhou,Bin Liu Chem. Commun., 2018,54, 10092-10095
• 2. Examination of the hydrogen-bonding networks in small water clusters (n = 2–5, 13, 17) using absolutely localized molecular orbital energy decomposition analysis?
  Erika A. Cobar,Paul R. Horn,Robert G. Bergman,Martin Head-Gordon Phys. Chem. Chem. Phys., 2012,14, 15328-15339
• 3. Fast synthesis of red Li3BaSrLn3(WO4)8:Eu3+ phosphors for white LEDs under near-UV excitation by a microwave-assisted solid state reaction method and photoluminescence studies
  Bo Wei,Zhenyu Liu,Chen Xie,Shu Yang,Wentao Tang,Aiwei Gu,Wing-Tak Wong,Ka-Leung Wong J. Mater. Chem. C, 2015,3, 12322-12327
• 4. Excited state potential energy surfaces and their interactions in FeIVO active sites
  Shaun D. Wong,Edward I. Solomon Dalton Trans., 2014,43, 17567-17577
• 5. Evolution study of photo-synthesized gold nanoparticles by spectral deconvolution model: a quantitative approach
  Chung-Sung Yang,Mong-Shian Shih,Fang-Yi Chang New J. Chem., 2006,30, 729-735

• Solvents and Organic Chemicals Organic Compounds Benzenoids Naphthalenes Naphthols and derivatives

Recent Advances in the Study of 7,8-Difluoronaphthalen-2-ol (CAS: 675132-42-0) in Chemical Biology and Pharmaceutical Research

The compound 7,8-Difluoronaphthalen-2-ol (CAS: 675132-42-0) has recently garnered significant attention in the field of chemical biology and pharmaceutical research due to its unique structural properties and potential therapeutic applications. This naphthalene derivative, characterized by the presence of fluorine atoms at the 7 and 8 positions and a hydroxyl group at the 2 position, exhibits remarkable chemical stability and bioactivity. Recent studies have explored its role as a key intermediate in the synthesis of novel bioactive molecules, particularly in the development of fluorinated pharmaceuticals, which are known for their enhanced metabolic stability and membrane permeability.

One of the most notable advancements in the study of 7,8-Difluoronaphthalen-2-ol is its application in the design of enzyme inhibitors. Researchers have demonstrated that this compound can serve as a scaffold for developing selective inhibitors of kinases and other enzymes involved in critical cellular pathways. For instance, a 2023 study published in the Journal of Medicinal Chemistry highlighted the compound's ability to modulate the activity of protein kinases implicated in cancer progression. The study utilized molecular docking and kinetic assays to elucidate the binding interactions between 7,8-Difluoronaphthalen-2-ol and the target enzymes, providing valuable insights for structure-based drug design.

In addition to its role in enzyme inhibition, 7,8-Difluoronaphthalen-2-ol has shown promise in the field of fluorescent probes and imaging agents. The fluorinated naphthalene core of the compound exhibits strong fluorescence properties, making it an attractive candidate for bioimaging applications. A recent study in Analytical Chemistry reported the synthesis of a series of fluorescent probes based on 7,8-Difluoronaphthalen-2-ol, which were used to detect reactive oxygen species (ROS) in live cells. These probes demonstrated high sensitivity and selectivity, offering a powerful tool for studying oxidative stress in biological systems.

Another area of interest is the compound's potential as a building block for the synthesis of advanced materials. Researchers have explored its incorporation into polymers and nanomaterials, leveraging its fluorinated aromatic structure to enhance material properties such as thermal stability and chemical resistance. A 2022 study in ACS Applied Materials & Interfaces detailed the use of 7,8-Difluoronaphthalen-2-ol in the development of high-performance polymers for biomedical applications, including drug delivery systems and tissue engineering scaffolds.

Despite these promising developments, challenges remain in the large-scale synthesis and optimization of 7,8-Difluoronaphthalen-2-ol for clinical and industrial applications. Current synthetic routes often involve multi-step processes with moderate yields, prompting ongoing research into more efficient and sustainable methodologies. Recent efforts have focused on catalytic fluorination and green chemistry approaches to improve the scalability and environmental impact of production.

In conclusion, 7,8-Difluoronaphthalen-2-ol (CAS: 675132-42-0) represents a versatile and valuable compound in chemical biology and pharmaceutical research. Its applications span from drug discovery and bioimaging to advanced materials, underscoring its broad utility. Future research will likely focus on refining synthetic methods, expanding its therapeutic potential, and exploring novel applications in emerging fields such as nanomedicine and diagnostics. As the scientific community continues to uncover the full potential of this compound, it is poised to play a pivotal role in advancing both fundamental and applied research in the life sciences.

• 13916-98-8(8-Fluoronaphthalen-2-OL)
• 13101-83-2(2-Naphthalenol,6-fluoro-)
• 675132-39-5(2-Naphthalenol, 5,6,7-trifluoro-)
• 383155-01-9(1-Naphthalenol,8-fluoro-(9CI))
• 61761-32-8(5-Fluoronaphthalen-1-ol)
• 2713-33-9(3,4-Difluorophenol)
• 321319-15-7(2-Naphthalenol,5,6-difluoro-)
• 8068-44-8(6-Fluoronaphthalen-1-ol)
• 741693-88-9(5-Fluoro-2-naphthalenol)
• 315-53-7(4-Fluoro-1-naphthalenol)